BioSpace News Archive

Business

SenTec Inc. Selects Rhode Island for Regional Headquarters

The company will utilize their new headquarters for more efficient distribution and expanded capabilities

December 19, 2019
·
2 min read
Lone Star Bio

Researchers ID Possible Mechanism to Prevent the Spread of Melanoma

What they found was that melanoma cells are more likely to metastasize through the body if their cells have high concentrations of MCT1 on their cell surface.

December 19, 2019
·
2 min read
·
Mark Terry
Drug Development

Xenikos announces first patient receives T-Guard® for steroid-refractory acute GVHD in pivotal U.S.-based Phase 3 trial

Xenikos B.V. announced that the first patient has been treated in their U.S.-based Phase 3 registration trial designed to evaluate the use of T-Guard for treating steroid-refractory acute graft-versus-host disease in patients following allogeneic stem cell transplantation.

December 19, 2019
·
5 min read
Drug Development

MC2 Therapeutics Announces Positive Top-line Results from EU Phase 3 Head-to-Head Trial Comparing Wynzora™ Cream to Daivobet® Gel in Patients with Psoriasis

MC2 Therapeutics announced that its EU Phase 3 trial on the company’s investigational drug, Wynzora™ Cream, met its primary endpoint and that a Marketing Authorization Application is now in preparation for H1 2020.

December 19, 2019
·
4 min read
Drug Development

Minerva MDD Treatment Fails Mid-Stage Trial, Company Has No Further Development Plans

Shares of Minerva Neurosciences are down more than 22% in premarket trading after the company announced late Wednesday that its Phase IIb major depressive disorder (MDD) trial failed to meet primary and key secondary endpoints.

December 19, 2019
·
2 min read
·
Alex Keown
Business

Arcus and Roche Partner on Colorectal and Pancreatic Cancer Trials

Arcus Biosciences and Genentech, a Roche company, are partnering on two clinical trials for colorectal and pancreatic cancer. They will evaluate Arcus’s AB928 in various combinations.

December 19, 2019
·
2 min read
·
Mark Terry
Drug Development

Astellas and Seattle Genetics Win Accelerated Approval for Bladder Cancer Drug

The FDA granted Astellas Pharma and Seattle Genetics accelerated approval for Padcev, a first-of-its-kind treatment for adult patients with metastatic urothelial bladder cancer.

December 19, 2019
·
3 min read
·
Alex Keown
Deals

CPhI & P-MEC India 2019 growth mirrors the market’s positive outlook heading into 2020

This year’s edition saw a rise in overall attendees, with harmonization and innovation driving increased industry dynamism

December 19, 2019
·
6 min read
Drug Development

Topas Therapeutics Announces First Patient Enrolled in Phase 1 Trial with TPM203 in Pemphigus Vulgaris

Topas Therapeutics GmbH announced that the first patient has been enrolled in a first-in-human Phase 1 trial evaluating TPM203 in patients with pemphigus vulgaris, an orphan autoimmune disease.

December 19, 2019
·
4 min read
Deals

Genomill Health Closes Investment Round To Expand Beta-testing With Liquid Biopsy Players

Genomill Health closes a financing round led by a deep tech VC Voima Ventures to expand its novel and disruptive technology, focusing on efficient use of NGS in liquid biopsies for cancer diagnostics.

December 19, 2019
·
3 min read